Building a new path to make medicines with AI

Isomorphic Labs is building an integrated AI-driven platform to revolutionise drug discovery by designing and optimising novel medicines from first principles, moving beyond empirical methods to engineered molecular design. Their AI platform, IsoDDE, advances beyond protein structure prediction to accelerate molecule design and pre-clinical development, promising scalable impact across multiple disease areas.

This Wire brief sits within Fusion42's coverage of Biotech, Drug Discovery and AI Frontier Models.